April 13, 2021

Within3 in Cleveland Business Journal

Within3 CEO Lance Hill talks about business growth during a pandemic, the company’s role in industry discussions around COVID-19, and what keeps him up at night.

Cleveland Business Journal sat down with Within3 CEO Lance Hill to tackle a number of topics in a recent Q&A. Hill discussed the strengths of Cleveland’s life science industry – including the lower cost of entry and increasing access to capital – as well as how he sees the future of Within3 unfolding. As for what keeps him up at night? “Am I doing everything I can think of to grow faster?”

Read the entire article (subscription may be required)

Related Posts:

Within3 CEO Lance Hill on digital transformation for CROs

Within3 CEO Lance Hill recommends four essential steps for contract research organizations embarking on digital transformation.
pharma industry lessons learned

Within3 in European Pharmaceutical Manufacturer: looking back, forging ahead

Our experts weigh in on more trends and predictions for 2023.
insights innovation for medical affairs

CEO Lance Hill in Gold Magazine

Medical affairs organizations are seeking effective applications for advanced technologies.